Skip to main content

Closed

ROIV: Roivant Sciences Ltd. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-11.2% / yr

Operating margin-15560.6%

ROIC-23.5%

Financially safe

Stretched

Debt / equity0.02×

Interest coverage0.0×

Current ratio18.37×

Roivant Sciences Ltd.

ROIVNASDAQ Global Market·USD·Closed

Roivant Sciences Ltd.

ROIVNASDAQ·USD·Closed

$33.91

−1.77%

$33.91

−$0.61 (1.77%)

52W Range

88thpctl

Volume

0.89×avg

Mkt Cap

24.50BUSD

P/E

-75.4TTM

Div Yield

–ann

52W Range

88thpctl

Volume

0.89×avg

Market Cap

24.50BUSD

P/E Ratio

-75.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings